Zovirax Sales Force To Increase Six Fold Based On Biovail Agreement With Sciele
This article was originally published in The Pink Sheet Daily
Promotional deal includes profit-sharing arrangement based on revenue targets for an initial term of five years.
You may also be interested in...
With the potential entry of generic Wellbutrin XL looming, Biovail cuts 200-person commercial organization in the U.S.
Andrx divests extended-release metformin and extended-release lovastatin to First Horizon for upfront payment of $50 mil. First Horizon's promotional efforts will focus on growing Fortamet and stabilizing Altoprev's declining market share.
Firm notes strong uptake of the product in 2006, as well as more than $400 million in Thalomid sales for the year during earnings call.